Professional Field
Specializing in the diagnosis and correction of chest wall deformities, particularly in the field of ultra-minimally invasive surgical treatment for congenital thoracic deformities such as pectus excavatum and pectus carinatum, the institution holds internationally leading expertise. With nearly 35 years of clinical experience in cardiothoracic surgery, it has performed over 3,000 cases of chest wall orthopedic procedures. Its innovative ultra-minimally invasive orthopedic plates and surgical techniques have been awarded the Shanghai Gold Medal for Outstanding Invention and granted national patents.
Academic and Clinical Background
Director Li Guoqing has long been dedicated to the basic and clinical research of chest wall deformities, having presided over multiple provincial and ministerial-level research projects.
His primary clinical research focuses include:
1. Development and Optimization of Ultra-minimally Invasive Treatment Technology for Thoracic Wall Malformations
2. Surgical Treatment Strategies for Complex and Recurrent Pectus Excavatum
3. Application of Personalized 3D Printing Implant in Thoracic Deformity
4. Practice of Enhanced Recovery After Surgery (ERAS) in Thoracic Surgery
He has published over 20 papers in SCI-indexed and core journals, and filed 12 patents related to thoracic surgery. His clinical expertise and innovative achievements have established him as one of the most accomplished experts in China, with the highest number of thoracic wall deformity surgeries performed and the highest patient satisfaction rates.
Ultra-minimally invasive surgery: Using the patented plate and technology developed by Director Li, the incision is smaller, the stripping is less, the pain is less, and the recovery is significantly accelerated.
Safety escort: Conventional application of the "sternal elevation" technique, which temporarily lifts the depressed sternum before the insertion of the steel plate, creates a safe space for surgical operation and greatly reduces the risk of cardiac injury.
Personalized reconstruction: Surgical simulation based on 3D printing models to customize personalized plates for patients, aiming for the ideal effect of "total chest wall reconstruction" rather than merely elevating the depressed points.
Why choose the team led by Director Li Guoqing for the treatment of pectus excavatum?
Director Li Guoqing is a leading expert in the Department of Thoracic Surgery at the Ninth People's Hospital affiliated with Shanghai Jiao Tong University School of Medicine, with nearly 35 years of dedicated experience in the field of chest wall deformities. He is not only an expert in traditional minimally invasive surgery but also a pioneer in the ultra-minimally invasive correction technique for pectus excavatum.
Innovative ultra-minimally invasive technique achieves therapeutic revolution: The ultra-minimally invasive pectus excavatum corrective plate and surgical method designed by Director Li Guoqing and granted a national patent are acclaimed by the industry as a revolutionary breakthrough in the history of pectus excavatum treatment. Compared with traditional surgical approaches, this technique involves less trauma and faster recovery, marking a leap from "minimally invasive" to "ultra-minimally invasive."
Integrating cutting-edge international concepts to deliver precision-tailored solutions: The team deeply incorporates the latest global technologies, such as 3D printing and personalized implant customization, mandatory sternotomy (significantly enhancing surgical safety), and the "total chest wall reconstruction" concept. These approaches not only correct deformities but also comprehensively restore thoracic morphology, providing each patient with a precise and individualized surgical plan.
Extensive experience in complex cases: Performs a large number of pectus excavatum corrective surgeries annually, with unique expertise in managing severe adult pectus excavatum, postoperative recurrent deformities, and complex cases complicated by scoliosis.
Comprehensive non-surgical therapy system: For mild cases or specific patients, provide scientifically validated vacuum bell negative pressure suction therapy, and may employ radiation-free white light scanning technology for efficacy monitoring to avoid repeated CT examinations.
